Company / Depreciation & Amortization
Crinetics Pharmaceuticals, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.9M
FY2025
5-year range
$922.0K / $3.9M
FY2021-FY2025
Trend
+39.3%
vs FY2024
Sector context
#82 of 168
Health Care
What the data says
At $4M, Crinetics Pharmaceuticals, Inc.'s depreciation & amortization ranks #87 of 168 in the Health Care sector. Depreciation & Amortization has increased for 7 consecutive years, from $92,000 in FY2018 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +52.6%.
Increased from $1M to $4M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +58.3%
- 5-Year CAGR
- +52.6%
- 10-Year CAGR
- -
Sector benchmark
#87 of 168 in Health CareTop 51% of 168This company $3.9M Sector average $212.9M
▼
-98.2% below sector average
Key checks
Key Insights
- Crinetics Pharmaceuticals, Inc.'s depreciation & amortization has grown for 7 consecutive years.
- 5-year CAGR of +52.6%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 39.3% year-over-year.
- Ranks #82 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9M | +39.3% |
| FY2024 | $2.8M | +154.5% |
| FY2023 | $1.1M | +11.9% |
| FY2022 | $983.0K | +6.6% |
| FY2021 | $922.0K | +95.8% |
| FY2020 | $471.0K | +268.0% |
| FY2019 | $128.0K | +39.1% |
| FY2018 | $92.0K | -28.1% |
| FY2017 | $128.0K | +39.1% |
| FY2016 | $92.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026